Definitive Healthcare Names Clay Ritchey CEO as Kevin Coop Departs
DH sits 56% above its 52-week low of $0.61.
Summary
Definitive Healthcare appointed Clay Ritchey as CEO effective September 8, 2026, succeeding Kevin Coop who departed August 31. The leadership change occurs against a backdrop of declining revenue, a Nasdaq delisting notice, and a pending buyout proposal from Advent International.
Key Events · Executive and Board Changes · DH
-
CEO Transition
Clay Ritchey appointed CEO and board member effective September 8, 2026, succeeding Kevin Coop who departed August 31, 2026.
-
Compensation Package
Ritchey receives $500,000 base salary, 87.5% target bonus, and $4 million in new hire equity (65% time-based RSUs, 35% performance-based RSUs).
-
Change-in-Control Severance
If terminated within 3 months before or 18 months after a change in control, Ritchey receives 18 months salary, 1.5x target bonus, and full equity acceleration — relevant to the pending Advent buyout proposal.
-
Strategic Context
The CEO change follows a 9% YoY revenue decline in Q2 2026, a Nasdaq delisting notice with a December 15, 2026 deadline, and Advent International's $1.02 per share buyout proposal.
Analysis · DH · Technology
Definitive Healthcare replaced CEO Kevin Coop with Clay Ritchey, a healthcare technology veteran, effective September 8, 2026. The transition comes amid a 9% revenue decline, a Nasdaq delisting notice, and a pending $1.02 per share buyout proposal from Advent International. Ritchey's compensation package includes a $500,000 base salary, 87.5% target bonus, and $4 million in new hire equity, with enhanced severance if terminated following a change in control — a provision directly relevant to the pending Advent proposal.
How filings like this one have moved
In the 30 days to Sep 10, 2026, 30.2% of the 2009 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.11%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, DH was trading at $0.95 on NASDAQ in the Technology sector, with a market capitalization of approximately $130.7M. The 52-week trading range was $0.61 to $4.35. This filing was assessed with neutral market sentiment and an importance score of 7 out of 10.